Medigene AG (MDGEF)
MDGEF Stock Price Chart
Explore Medigene AG interactive price chart. Choose custom timeframes to analyze MDGEF price movements and trends.
MDGEF Company Profile
Discover essential business fundamentals and corporate details for Medigene AG (MDGEF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Jun 2013
Employees
87.00
Website
https://www.medigene.comCEO
Selwyn Ho MB BS, MBBS
Description
Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on developing and marketing RhuDex for hepatology and gastroenterology indications. Medigene AG has a strategic partnership with 2seventy bio, Inc. for the development of T cell receptors. The company also has research collaboration agreements on novel cancer antigens for immunotherapies with the Université de Montréal; and with Cytovant Sciences Co. Ltd. It has operations in Europe, the United States, Asia, and internationally. The company was founded in 1994 and is headquartered in Munich, Germany.
MDGEF Financial Timeline
Browse a chronological timeline of Medigene AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Oct 2025
Earnings released on 31 Jul 2025
Earnings released on 28 Apr 2025
Earnings released on 28 Mar 2025
Earnings released on 24 Oct 2024
Stock split effective on 29 Aug 2024
Shares were split 1 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Aug 2024
EPS came in at -$0.16 surpassing the estimated -$0.60 by +73.09%, while revenue for the quarter reached $1.57M , missing expectations by -64.76%.
Earnings released on 26 Apr 2024
Earnings released on 28 Mar 2024
EPS came in at -$0.21 surpassing the estimated -$1.07 by +80.72%, while revenue for the quarter reached $1.63M , missing expectations by -46.00%.
Earnings released on 8 Jan 2024
EPS came in at -$0.20 , while revenue for the quarter reached $1.57M .
Earnings released on 17 Aug 2023
EPS came in at -$0.17 , while revenue for the quarter reached $1.67M .
Earnings released on 30 Jun 2023
EPS came in at -$0.18 surpassing the estimated -$0.79 by +77.10%, while revenue for the quarter reached $1.69M , missing expectations by -37.99%.
Earnings released on 29 Mar 2023
EPS came in at -$0.49 , while revenue for the quarter reached $3.21M .
Earnings released on 2 Nov 2022
EPS came in at -$0.44 , while revenue for the quarter reached $2.91M .
Earnings released on 3 Aug 2022
EPS came in at -$0.10 , while revenue for the quarter reached $2.37M .
Earnings released on 4 May 2022
EPS came in at $0.31 , while revenue for the quarter reached $13.98M .
Earnings released on 23 Mar 2022
EPS came in at -$0.19 , while revenue for the quarter reached $7.00M .
Earnings released on 11 Nov 2021
EPS came in at -$0.10 , while revenue for the quarter reached $3.58M .
Earnings released on 13 Aug 2021
EPS came in at -$0.26 , while revenue for the quarter reached $5.09M .
Earnings released on 5 Apr 2021
EPS came in at -$0.14 , while revenue for the quarter reached $2.52M .
Earnings released on 31 Dec 2020
EPS came in at -$0.77 , while revenue for the quarter reached $5.31M .
Earnings released on 12 Nov 2020
EPS came in at -$0.39 , while revenue for the quarter reached $2.54M .
MDGEF Stock Performance
Access detailed MDGEF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.